Tom van den Ende

12PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersBiomedical fluid mechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 08, 2026
Second-line oxaliplatin reintroduction or paclitaxel-ramucirumab in metastatic gastroesophageal cancer: a population-based study.

|Jan 13, 2025
Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profiling.

Li-Ting Chen, Myrthe Jager, Dàmi Rebergen

|Jun 26, 2024
Fecal, duodenal, and tumor microbiota composition of esophageal carcinoma patients, a longitudinal prospective cohort.

Tom van den Ende, Nicolien C de Clercq, Mark Davids

|Nov 28, 2023
High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy.

Dingpei Han, Yichao Han, Wei Guo

|Aug 24, 2023
Genome-wide and panel-based cell-free DNA characterization of patients with resectable esophageal adenocarcinoma.

Tom van den Ende, Ymke van der Pol, Aafke Creemers

|Jul 20, 2023
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition.

Tom van den Ende, Aiarpi Ezdoglian, Lisanne M Baas

Pageof 2

Frequent Collaborators

2 joint publications

Suzanne S Gisbertz

1 joint publications

Martijn G H van Oijen

1 joint publications

Hanneke W M van Laarhoven

1 joint publications

Mark I van Berge Henegouwen